Home › Funds › UBS Group AG › CLOV
UBS Group AG position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q2 2026)409.45K sh
Reported value held$2.15M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 8.62K | $64.00K | New |
| Q4 2021 | 300 | $1.00K | Reduce |
| Q1 2022 | 12.26K | $44.00K | Add |
| Q2 2022 | 35.17K | $75.00K | Add |
| Q3 2022 | 3.67K | $6.00K | Reduce |
| Q4 2022 | 28.77K | $26.75K | Add |
| Q1 2023 | 3.50K | $2.96K | Reduce |
| Q2 2023 | 5.73K | $5.14K | Add |
| Q3 2023 | 52.57K | $56.77K | Add |
| Q4 2023 | 124.99K | $118.99K | Add |
| Q1 2024 | 242.49K | $192.54K | Add |
| Q2 2024 | 71.74K | $88.24K | Reduce |
| Q3 2024 | 32.55K | $91.78K | Reduce |
| Q4 2024 | 171.32K | $539.65K | Add |
| Q1 2025 | 530.90K | $1.91M | Add |
| Q2 2025 | 893.35K | $2.49M | Add |
| Q3 2025 | 2.28M | $6.98M | Add |
| Q4 2025 | 1.32M | $3.09M | Reduce |
| Q1 2026 | 1.77M | $3.11M | Add |
| Q2 2026 | 409.45K | $2.15M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Citadel Advisors 4.38M sh · $22.94M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Marshall Wace 1.56M sh · $8.19M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026